GEPL Hot Stocks – Jubilant Organosys (video)


We at GEPL have initiated coverage on Jubilant Organosys at the price of Rs 350 and a target of Rs 444 with a one year horizon. In the CRAMS segment which is due for a positive turnaround, Jubilant is one of the leading players. It is the one-stop destination providing contract research, custom synthesis, API manufacturing and dosage forms manufacturing as well. Its varied business segments are well poised for growth. The de-merger of the APP business segment is the trigger for value unlocking. The chain of acquisitions has augured well for the company. Also the company is enhancing capacities and investments across different business segments. Thus, Jubilant is strongly placed to capitalize on the emerging opportunities from the outsourcing market with growth visibility rendering valuations attractive for the company.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s